- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 211/26 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
Patent holdings for IPC class C07D 211/26
Total number of patents in this class: 400
10-year publication summary
|
32
|
39
|
21
|
22
|
16
|
30
|
15
|
25
|
19
|
23
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Praxis Precision Medicines, Inc. | 238 |
11 |
| Incyte Corporation | 1068 |
10 |
| Janssen Pharmaceutica N.V. | 3142 |
9 |
| Incyte Holdings Corporation | 619 |
9 |
| Novartis AG | 10172 |
7 |
| Concentric Analgesics, Inc. | 11 |
7 |
| Boehringer Ingelheim International GmbH | 4480 |
6 |
| Glaxosmithkline Intellectual Property Development Limited | 785 |
6 |
| ChemoCentryx, Inc. | 361 |
6 |
| Richter Gedeon Nyrt. | 1703 |
6 |
| Libertas bio, Inc. | 22 |
6 |
| FUJIFILM Corporation | 30774 |
5 |
| The Trustees of the University of Pennsylvania | 4441 |
5 |
| Oryzon Genomics S.A. | 103 |
5 |
| VP Asset Holdings, LLC | 12 |
5 |
| Hoffmann-La Roche Inc. | 3849 |
4 |
| Glaxosmithkline Intellectual Property (no.2) Limited | 312 |
4 |
| Massachusetts Institute of Technology | 10313 |
4 |
| Astellas Pharma Inc. | 1039 |
4 |
| George Mason Research Foundation, Inc. | 97 |
4 |
| Other owners | 277 |